Identification of KMT2A-ARHGEF12 fusion in a child with a high-grade B-cell lymphoma

Cancer Genet. 2021 Nov:258-259:23-26. doi: 10.1016/j.cancergen.2021.06.006. Epub 2021 Jun 27.

Abstract

Rearrangements involving KMT2A are common in de novo and therapy-related acute myeloid and lymphoblastic leukemias. There is a diverse recombinome associated with KMT2A involving at least 135 partner genes, with more being discovered due to advances in molecular genetic diagnostics. KMT2A-ARHGEF12 fusion has only rarely been reported, in five cases of acute leukemia and a single case of high-grade B-cell lymphoma. We present a 12-year-old boy with high-grade B-cell lymphoma and KMT2A-ARHGEF12 fusion, whose clinical, morphologic, phenotypic and genotypic profile is strikingly similar to the other case of high grade B cell lymphoma, both otherwise perfectly mimicking Burkitt lymphoma.

Keywords: ARHGEF12; B-cell lymphoma; Genomic microarray analysis; KMT2A; Next generation sequencing.

Publication types

  • Case Reports

MeSH terms

  • Child
  • Gene Rearrangement*
  • Histone-Lysine N-Methyltransferase / genetics*
  • Humans
  • Lymphoma, B-Cell / genetics
  • Lymphoma, B-Cell / pathology*
  • Male
  • Myeloid-Lymphoid Leukemia Protein / genetics*
  • Oncogene Proteins, Fusion / genetics*
  • Prognosis
  • Rho Guanine Nucleotide Exchange Factors / genetics*

Substances

  • ARHGEF12 protein, human
  • KMT2A protein, human
  • Oncogene Proteins, Fusion
  • Rho Guanine Nucleotide Exchange Factors
  • Myeloid-Lymphoid Leukemia Protein
  • Histone-Lysine N-Methyltransferase